EMIT Imaging logo

EMIT Imaging

Industry-leading CFT instrument & services provider: 3D imaging tool to monitor drug distribution and protein expression

21 employees · est. 2018 · Baltimore, United States

VS
Ionpath logo

Ionpath

Enabling precision medicine through high-definition spatial proteomics

32 employees · est. 2014 · Menlo Park, United States

Ionpath is the older company (2018 vs 2014).

Side-by-Side Comparison

EMIT Imaging Ionpath
Founded
2018 2014 older
Headquarters
Baltimore, United States Menlo Park, United States
Employees
21 32
Industry
Biotechnology Biotechnology, Health Care
Funding Stage
Debt Financing Corporate Round
Total Funding
$6.40M $18.00M
Funding Rounds
2 4
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Cryo-Fluorescence Tomography, 3D Imaging, Drug Distribution, Protein Expression, Preclinical Imaging, Biology Research, Drug Research, Instrumentation, Imaging Platform, Therapeutic Protein, Drug Delivery, Multiplexed Co-localization, Biological Discoveries, In Vivo Fluorescence Imaging, Tissue Samples Medical Imaging, Ion Beam Technology, Cancer Diagnosis, Tissue Analysis, Biopsy Technology, Precision Medicine, Biomedical Technology
Website
emitimaging.com ionpath.com
EMIT Imaging logo

About EMIT Imaging

EMIT Imaging is a biotechnology startup founded in 2018, headquartered in the United States. Specializing in Cryo-Fluorescence Tomography (CFT), they provide a novel, 3D imaging tool for monitoring drug distribution and protein expression in whole animals and large tissue samples. Their platform, Xe...

Ionpath logo

About Ionpath

Ionpath has developed advanced ion beam imaging technology to revolutionize cancer diagnosis, with the aim of contributing to the improvement of human health. This innovation enables the precise examination of tissue biopsies, surpassing the capabilities of light microscopy. By catering to various t...

We will tell you when either one moves

BounceWatch watches EMIT Imaging and Ionpath for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at EMIT Imaging and Ionpath — by email.

Frequently Asked Questions

EMIT Imaging — Industry-leading CFT instrument & services provider: 3D imaging tool to monitor drug distribution and protein expression. Ionpath — Enabling precision medicine through high-definition spatial proteomics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
EMIT Imaging has raised $6.40M while Ionpath has raised $18.00M.
EMIT Imaging and Ionpath operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare EMIT Imaging with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at EMIT Imaging on 12 Sep 2024, and Ionpath on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy